咨询与建议

限定检索结果

文献类型

  • 1 篇 期刊文献

馆藏范围

  • 1 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 1 篇 医学
    • 1 篇 中西医结合
    • 1 篇 药学(可授医学、理...

主题

  • 1 篇 combination trea...
  • 1 篇 in vivo study
  • 1 篇 tepotinib
  • 1 篇 chemotherapy
  • 1 篇 multidrug resist...
  • 1 篇 reversal agent
  • 1 篇 met inhibitor
  • 1 篇 abcg2 transporte...

机构

  • 1 篇 department of ra...
  • 1 篇 department of ph...
  • 1 篇 department of an...

作者

  • 1 篇 jian wang
  • 1 篇 zhuo-xun wu
  • 1 篇 nikita acharekar
  • 1 篇 jing-quan wang
  • 1 篇 min he
  • 1 篇 yuqi yang
  • 1 篇 sabesan yoganath...
  • 1 篇 jun lin
  • 1 篇 zhe-sheng chen
  • 1 篇 qiu-xu teng

语言

  • 1 篇 英文
检索条件"作者=nikita acharekar"
1 条 记 录,以下是1-10 订阅
排序:
MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter:In vitro and in vivo study
收藏 引用
Acta Pharmaceutica Sinica B 2022年 第5期12卷 2609-2618页
作者: Zhuo-Xun Wu Qiu-Xu Teng Yuqi Yang nikita acharekar Jing-Quan Wang Min He Sabesan Yoganathan Jun Lin Jian Wang Zhe-Sheng Chen Department of Pharmaceutical Sciences College of Pharmacy and Health SciencesSt.John’s UniversityQueensNY 11439USA Department of Anesthesiology Stony Brook University Health Sciences CenterStony BrookNY 11794USA Department of Radiotherapy the Affiliated Jiangyin People’s Hospital of Nantong UniversityJiangyin 214400China
Overexpression of ABCG2 transporter in cancer cells has been linked to the development of multidrug resistance(MDR), an obstacle to cancer therapy. Our recent study uncovered that the MET inhibitor,tepotinib, is a pot... 详细信息
来源: 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论